A review on co-existent Epstein–Barr virus-induced complications in inflammatory bowel disease
Authors:
- 1 September 2019
- journal article
- review article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 31 (9) , 1085-1091
Abstract
There have been growing reports regarding the presence of Epstein–Barr virus (EBV) in the intestine portions of patients suffering from ulcerative colitis and Crohn’s disease, collectively termed as inflammatory bowel disease (IBD). Indeed, the prevalence of EBV infection increases in IBD patients due to prolonged employment of immunosuppressive drugs including azathioprine and infliximab. In turn, coinfection with EBV increases the propensity of development of lymphoproliferative disorders in the gastrointestinal tract including Hodgkin lymphoma, non-Hodgkin lymphomas, and lymphoepithelioma-like cholangiocarcinoma. Therefore, it is recommended that IBD patients on prolonged immunomodulator therapy should be monitored for the presence of primary intestinal lymphoproliferative diseases. Moreover, coinfection of EBV complicates the clinical course of IBD by increasing the severity, chronicity, inducing refractoriness and increasing relapse incidences. Therefore, it is recommended that antiviral drugs should be added in the conventional IBD therapy in the suspected cases of EBV infection. Research has also revealed that EBV-induced colitis is very similar to IBD and there are chances of misdiagnosis of IBD in the presence of EBV colitis. The proper diagnosis of EBV infection along with its timely treatment is necessary to avoid the severe complications in patients of IBD. The present review discusses the role of EBV coinfection in increasing the clinical complications of IBD patients.Keywords
This publication has 80 references indexed in Scilit:
- The Epstein–Barr virus and the pathogenesis of lymphomaThe Journal of Pathology, 2014
- Primary rectal diffuse large B‐cell lymphoma associated with ulcerative colitis: a case reportClinical Case Reports, 2014
- Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Epstein–Barr Virus and Parvovirus B19 Coinfection in a Crohnʼs Disease Patient Under AzathioprineInflammatory Bowel Diseases, 2010
- Epstein–Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohnʼs diseaseInflammatory Bowel Diseases, 2009
- A steroid-refractory ulcerative colitis revealing Epstein–Barr virus/cytomegalovirus-positive colonic lymphomaInternational Journal of Colorectal Disease, 2005
- Epstein–barr virus (EBV) infection and expression of the interleukin‐12 family member EBV‐induced gene 3 (EBI3) in chronic inflammatory bowel diseaseJournal of Medical Virology, 2004
- Epstein–Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomasThe Journal of Pathology, 2003
- Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reactionJournal of Medical Virology, 1992
- Epstein-barr virus and inflammatory bowel diseaseCellular and Molecular Life Sciences, 1971